bioRxiv Science⌕ Search

bioRxiv · 10.1101/2024.03.27.586810

inSequio: A Programmable 3D CAD Application for Designing DNA Nanostructures

Abstract

DNA nanotechnology is evolving rapidly, paralleling the historic trajectory of the 1970s electronics industry. However, current DNA nanostructure (DN) design software limits users to either manual design with minimal automation or a constrained range of automated designs. inS[e]quio Design Studio, developed by Parabon(R) NanoLabs, bridges this gap as a programmable 3D computer-aided design (CAD) application, integrating a domain-specific graphical editor with a Python API for versatile DN design. Developed in C++ for Windows(R) and Macintosh(R) systems, inS[e]quio features a user-friendly GUI with extensive CAD tools, capable of managing complex designs and offloading computational tasks to the cloud. It supports various DNA design formats, PDB molecule integration, residue modifications, and includes preloaded designs and thorough documentation. With its combination of features, inS[e]quio enables a code-centric design (CCD) approach, enhancing DN construction with improved precision, scalability, and efficiency. This approach is elucidated through a streptavidin barrel cage designed via Python notebook and a spheroid origami case study. Marking a significant advance in DN design automation, inS[e]quio, the first fully programmable 3D CAD tool for DN design, enables both manual and programmatic 3D editing. This fusion of features establishes inS[e]quio as a transformative tool, poised to significantly enhance designer productivity and expand the scope of possible designs. Extended AbstractAdvances in DNA nanotechnology have positioned the field at a juncture reminiscent of the pivotal growth phase of the electronics industry in the 1970s. The evolution of software for designing DNA nanostructures (DNs) is following a similar historical trajectory and dozens of software packages have been developed for creating them. Existing software options, however, require users to choose between manual design with minimal automation support or selecting from a limited set of designs, typically wireframe, that can be generated from a high-level structural description. Here, we introduce the inS[e]quio Design Studio, a programmable 3D computer-aided design (CAD) application that effectively bridges this gap. By integrating a domain-specific, freeform graphical editor with a Python application programming interface (API), inS[e]quio provides a comprehensive and extensible platform for designing complex nucleic acid (NA) nanostructures. The inS[e]quio desktop application, developed in C++, runs on Windows(R) and Macintosh(R) operating systems. Its graphical user interface (GUI) features multiple synchronized view panels and a diverse set of CAD and NA-specific editing tools. Its optimized graphics pipeline enables editing of designs with >2M nucleotides, and it includes an integrated service infrastructure for offloading heavy computations to cloud servers. The software also supports import and export of various DNA design file formats, integration of arbitrary PDB molecules, and specification of residue modifications. Additionally, it includes preloaded sample designs, scripts, and comprehensive documentation. Parabon has used evolving versions of inS[e]quio for over a decade to design a variety of proprietary DNs and have now transitioned it into a commercially available product. This paper summarizes inS[e]quios features, discusses its strengths and limitations, and outlines planned enhancements. Although freeform 3D design is well supported in inS[e]quio, the integration of its CAD environment with its API facilitates a code-centric design (CCD) approach for DN construction that offers notable productivity advantages over traditional methods, including enhanced precision, scalability, and efficiency. Here we describe CCD, outline its benefits and demonstrate its use through a well-documented Python notebook, included with the product, which generates a sample design within the inS[e]quio application. A spheroid origami created using CCD is also presented. As the first commercial fully programmable 3D CAD application specifically created for DN design, the release of inS[e]quio represents a milestone in the field of DN design automation. It introduces a new dimension to the discipline by enabling both manual and programmatic 3D editing, thereby facilitating an innovative CCD approach. The availability of extensive documentation and technical support enables designers to efficiently adopt and utilize these capabilities. This combination of features establishes inS[e]quio as a noteworthy addition to the tools available for DN design, with the potential to significantly increase designer productivity and broaden the scope of designs that can be developed by practitioners of all skill levels. Windows and Mac versions of the inS[e]quio desktop application are available for download at https://parabon.com/insequio. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=119 SRC="FIGDIR/small/586810v1_ufig1.gif" ALT="Figure 1"> View larger version (64K): org.highwire.dtl.DTLVardef@16a2714org.highwire.dtl.DTLVardef@2bc610org.highwire.dtl.DTLVardef@1d852e2org.highwire.dtl.DTLVardef@129b3fa_HPS_FORMAT_FIGEXP M_FIG C_FIG An illustration of the inS[e]quio Design Studio desktop application interoperating with a Python Jupyter notebook and molecular dynamics (MD) simulation tools to support an iterative code-centric design (CCD) process. The design cycle includes (a) programmatic and/or manual creation of objects in the inS[e]quio editors; (b) visual inspection and manipulation of objects via user interface; (c) in silico evaluation of designs via MD simulation using native or external tools; repeating a-c as necessary; and (d) procurement of strands and synthesis of DNA nanostructures (DNs).

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

LaRock, C., Sorensen, P., Blair, D., Murphy, D., O'Connor, J., Armentrout, S.. 2024-03-30. inSequio: A Programmable 3D CAD Application for Designing DNA Nanostructures. https://doi.org/10.1101/2024.03.27.586810

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Wall stiffening is a primary contributor to motility loss in Crohn's disease: an electromechanical modeling study

Fibrotic strictures are among the most disabling complications of Crohn's disease, permanently narrowing the bowel and impairing motility, yet no approved therapy reverses them. Chronic inflammation alters pacemaker-network coupling, smooth-muscle excitability, and calcium-dependent contractility, while fibrosis thickens the bowel wall, narrows the lumen, and changes tissue mechanics. The relative contributions of these coupled electrical, contractile, and structural alterations to motility loss remain unclear. To address this gap, we develop an integrated electromechanical finite-element framework for fibrostenosing Crohn's disease that couples a fibrosis-driven growth model with a FitzHugh-Nagumo electromechanical model. A full-factorial 25 design of experiments is used to quantify the relative effects of electrical diffusivity, excitation threshold, peak active stress, wall stiffness, and hypertrophic remodeling on cyclic lumen-volume deformation. Motility is quantified by the standard deviation of lumen volume over one contraction cycle. Within the parameter ranges examined, increased wall stiffness emerged as the dominant contributor to motility loss, followed by impaired smooth-muscle contractility. Changes in excitation threshold, hypertrophic remodeling, and electrical diffusivity produced substantially smaller effects. Pairwise interactions were small relative to the dominant main effects, indicating that the mechanisms contributed largely through their individual effects. Our findings suggest that limiting wall stiffening while preserving smooth-muscle contractile function may provide a therapeutic strategy for maintaining intestinal motility in fibrostenosing Crohn's disease.

bioengineering↗

Lactate Receptor Activation Alleviates Senescence and Preserves Homeostasis of Aged Arteries

Arteries are among the first tissues to exhibit age-related dysfunction, yet the metabolic mechanisms driving vascular senescence remain poorly understood. Here, analysis of human aortic transcriptomic data identified HCAR1, encoding the lactate receptor GPR81, as one of the genes most significantly downregulated with age. We therefore investigated whether age-associated loss of GPR81 contributes to cellular senescence within the vessel wall. Senescent human endothelial cells and vascular smooth muscle cells accumulated neutral and oxidized lipids and exhibited increased labile iron and ferroptosis. Silencing GPR81 in early-passage cells recapitulated this metabolic phenotype together with multiple hallmarks of cellular senescence. Moreover, endothelial-specific deletion of GPR81 in young mice was sufficient to induce senescent cell accumulation, impaired lipid homeostasis, endothelial dysfunction, and elastin disorganization. Conversely, pharmacological activation of GPR81 with the agonist CHBA restored fatty acid metabolism, promoted glycolytic reprogramming, and attenuated ferroptotic stress and senescence-associated phenotypes. In lamin A knock-in (LAKI) progeroid mice, CHBA reduced arterial lipid accumulation and cellular senescence, shifted vascular cell composition toward a youthful state, improved endothelial integrity, and restored extracellular matrix homeostasis. Together, these findings identify age-associated loss of GPR81 as a driver of vascular metabolic dysfunction and cellular senescence and establish pharmacological GPR81 activation as a promising therapeutic strategy for preserving vascular homeostasis and mitigating age-associated cardiovascular disease.

bioengineering↗

Targeted and bilateral blood flow monitoring in middle cerebral artery using diffuse correlation spectroscopy

Objective: To develop and validate a dual-probe Diffuse Correlation Spectroscopy (DCS) system for non-invasive and simultaneous, monitoring of cerebral blood flow (CBF) in the bilateral Middle Cerebral Artery (MCA) territories, and expanding the utility of conventional DCS limited to cortical-volume-based CBF measurements to vessel-specific cerebral perfusion monitoring. Methods: A dual-probe DCS system was designed for non-invasive monitoring of MCA-specific perfusion. Probe placement and protocol optimization study has been performed using anatomical landmarks, motor and speech activation tasks in healthy volunteers. System stability and repeatability were further evaluated in a pilot cohort of 30 healthy (age, 25{+/-}7 years) participants using optimized probe position and protocol. A bilateral MCA ischemic Lacunar Infract stroke case report also validated the feasibility of the system in clinical settings. Results: Measurements demonstrated superior sensitivity towards MCA-territory perfusion at targeted probe locations compared to off-MCA positions. In pilot cohort, significant increase of 30.34 {+/-} 21.56% and 36.48 {+/-} 21.22% in rCBF corresponding to hand squeeze and speech task respectively showed reproducible physiological responsiveness of the system (p<0.001). Measurement done on a patient with bilateral MCA ischemic Lacunar Infract stroke showed a significant change of 30% during speech for both the MCAs but no significant change is observed for hand squeeze tasks. Conclusion: The custom built dual-probe DCS system enables non-invasive, operator-independent, targeted and continuous monitoring of rCBF within bilateral MCA territories. Significance: This approach enables the potential use of DCS system for bilateral and vessel-specific monitoring of cerebral perfusion in the MCA territories.

bioengineering↗